BioCentury
ARTICLE | Clinical News

Dexilant dexlansoprazole regulatory update

December 5, 2011 8:00 AM UTC

FDA approved a label change for Dexilant dexlansoprazole to state that no dose adjustment is necessary when the drug is given in combination with Plavix clopidogrel. The change was based on results f...